FDA will not tolerate any negligence affecting health of donors and patients: Tukaram Mundhe, FDA Commissioner

Image for FDA will not tolerate any negligence affecting health of donors and patients: Tukaram Mundhe, FDA Commissioner

Imagine donating blood to save a life.

You roll up your sleeve. You trust the system.

Now imagine that blood was stored in a broken fridge.

Logged in a missing register.

Processed on equipment whose calibration expired months ago.

That's the nightmare Maharashtra's FDA just walked into.


🚨 Two blood banks. Shut down. Immediately.

On Friday, the Maharashtra FDA pulled the plug on:

  • πŸ₯ Sir J J Metropolitan Blood Centre, Mumbai

  • 🩸 Maya Blood Centre, Badlapur (Thane)

No collection. No processing. No distribution. No camps.

Everything β€” frozen.

And this wasn't a random raid.

FDA officers, along with the Central Drugs Standard Control Organisation (CDSCO), spent June 22 to 24 combing through both facilities after a tip-off about violations.

What they found was worse than expected.


πŸ” Inside Sir J J Metropolitan Blood Centre

The list reads like a regulator's worst fever dream:

  • ❄️ Broken storage and control systems for blood

  • πŸ§ͺ Reactive and expired blood bags handled improperly

  • ☣️ Biohazardous waste mishandled

  • βš™οΈ Malfunctioning equipment

  • 🚫 No essential sterilisation controls in the component prep section

  • πŸ“‰ Quality management system β€” failed

This isn't paperwork sloppiness.

This is the kind of chain-of-custody breakdown that ends with a contaminated transfusion.


🩸 Maya Blood Centre was somehow… worse

At the Badlapur facility, inspectors found:

  • πŸ“‹ Zero records for blood transported from donation camps

  • πŸ•΅οΈ No traceability for blood bags

  • πŸ‘€ No blood transfusion officer. No required technical staff.

  • ⏰ Equipment calibration β€” expired

  • 🧫 Quality control testing β€” missing

  • πŸ—‘οΈ Biomedical waste β€” mismanaged

  • πŸ“ Camps run without mandatory approvals or records

A blood bank operating like an unlogged warehouse.


⚑ The Commissioner didn't hold back

FDA Commissioner Tukaram Mundhe put it bluntly:

"The FDA will not tolerate any negligence or violation of rules affecting the health of blood donors and patients."

Show-cause notices have gone out.

Proceedings under the Drugs and Cosmetics Act, 1940 are rolling.

And this fits a wider pattern in Maharashtra this year β€” KEM Hospital's blood bank licence was suspended in May, KB Bhabha Hospital's for four days in April over similar lapses.

The crackdown is real. And it's accelerating.


🧠 Why this story matters beyond Mumbai

Blood isn't a product. It's a promise.

A promise that the bag hanging above a patient's bed is safe.

That the donor wasn't put at risk.

That someone, somewhere, actually checked.

When that promise breaks β€” quietly, behind a clinic wall β€” no one knows until someone gets sick.

Or worse.

Maharashtra's FDA just made sure two of those quiet breakdowns got very, very loud.

That's all for now!